ly 186126 has been researched along with cyclic gmp in 2 studies
Studies (ly 186126) | Trials (ly 186126) | Recent Studies (post-2010) (ly 186126) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
7 | 0 | 0 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | ly 186126 (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flawn, P; Loten, EG | 1 |
Kauffman, RF; Robertson, DW; Utterback, BG | 1 |
2 other study(ies) available for ly 186126 and cyclic gmp
Article | Year |
---|---|
Properties and distribution of cyclic AMP phosphodiesterase from rat liver.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Membrane; Chromatography; Chymotrypsin; Cyclic GMP; Indoles; Insulin; Kinetics; Liver; Microsomes, Liver; Octoxynol; Polyethylene Glycols; Pyridazines; Rats; Solubility | 1990 |
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding Sites; Cardiotonic Agents; Cyclic GMP; Dogs; Enzyme Activation; Hydrogen-Ion Concentration; Indoles; Ions; Membranes; Myocardium; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Sarcoplasmic Reticulum | 1989 |